Nota Bene Episode 119: The State of Competition in the U.S. Healthcare Industry with John Carroll
2020 brought about rapid change in the American healthcare industry. Many hospitals and healthcare providers are turning to mergers as a means of providing improved health services to the population at scale. These consolidations, however, do not occur without setting off antitrust alarms. In this episode, we’re exploring the current state of the U.S. healthcare system and the application of antitrust regulation in this space.
Joining Michael for this conversation is John D. Carroll. John is a partner in the Antitrust & Competition Practice Group in the Sheppard Mullin Washington, D.C. office. John’s practice focuses on civil and criminal antitrust matters, including mergers & acquisitions, strategic counseling and compliance, and global cartel investigations, where he represents clients before the Department of Justice Antitrust Division, Federal Trade Commission, and international and state antitrust enforcement authorities.
What We Discussed in This Episode:
- In what way was the revenue of American healthcare providers impacted in 2020?
- Despite the non-profit status of many hospitals, how might these entities trigger antitrust regulation?
- What is required in order to provide healthcare across a population of people?
- What is value-based care?
- How do hospital consolidations affect commercial payors (insurance companies)?
- What must the Federal Trade Commission present when bringing an antitrust case against an insurance company?
- What type of joint venture relationships, both traditional and non-traditional, are developing between various healthcare providers?
In the Matter of Thomas Jefferson University